Atlas Trials

A Clinical Study of Sintilimab Combined With Chemothrapy Versus Chemotherapy as Adjuvant Therapy for Gastric/Gastroesophageal Junction Adenocarcinoma

Clinical trial NCT07492615 · RECRUITING

Trial details

NCT number
NCT07492615
Sponsor
Fudan University
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Gastric Cancer or Gastroesophageal Junction Adenocarcinoma
Start date
2026-01-29
Primary completion
2029-02-20
Enrollment
276

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.